Zai Lab Limited
ZLAB · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $116 | $110 | $106 | $109 |
| % Growth | 5.6% | 3.3% | -2.4% | – |
| Cost of Goods Sold | $47 | $43 | $39 | $42 |
| Gross Profit | $69 | $67 | $68 | $67 |
| % Margin | 59.6% | 60.7% | 63.7% | 61.4% |
| R&D Expenses | $48 | $51 | $61 | $52 |
| G&A Expenses | $41 | $43 | $63 | $83 |
| SG&A Expenses | $70 | $71 | $63 | $83 |
| Sales & Mktg Exp. | $29 | $28 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $118 | $122 | $124 | $135 |
| Operating Income | -$49 | -$55 | -$56 | -$68 |
| % Margin | -42.1% | -49.9% | -52.9% | -62.2% |
| Other Income/Exp. Net | $13 | $14 | $8 | -$14 |
| Pre-Tax Income | -$36 | -$41 | -$48 | -$82 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$36 | -$41 | -$48 | -$82 |
| % Margin | -31% | -37% | -45.5% | -74.9% |
| EPS | -0.3 | -0.37 | -0.45 | -0.8 |
| % Growth | 18.9% | 17.8% | 43.8% | – |
| EPS Diluted | -0.3 | -0.37 | -0.45 | -0.8 |
| Weighted Avg Shares Out | 110 | 109 | 108 | 102 |
| Weighted Avg Shares Out Dil | 110 | 109 | 108 | 102 |
| Supplemental Information | – | – | – | – |
| Interest Income | $8 | $9 | $9 | $9 |
| Interest Expense | $1 | $1 | $1 | $1 |
| Depreciation & Amortization | $4 | $4 | $3 | $5 |
| EBITDA | -$31 | -$36 | -$44 | -$75 |
| % Margin | -26.4% | -32.5% | -41.1% | -69.2% |